We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecular Computers May Let Patients Diagnose and Treat Themselves

By Biotechdaily staff writers
Posted on 12 May 2004
A microscopic computer constructed from a portion of a DNA molecule has been successfully tested in vitro, suggesting that such a device might someday be able to detect the presence of a disease in an individual and then produce a drug molecule to combat it.

Investigators at the Weizmann Institute of Science (Rehovot, Israel; www.weizmann.ac.il) developed the molecular computing device, which is so small that nearly a trillion of them can be contained in 1 ml of liquid. More...
The molecular computing device belongs to the class of finite computers, which is a simplified version of the Turing machine, a mathematical model of computation developed by the British mathematician Alan Turing in the 1930s. As such, the molecular computer has three components: an input molecule, which stores the data to be processed as well as the fuel needed for the computation; software molecules, which encode program rules; and a hardware molecule that performs the computation, as directed by the software and the input. The molecules are suspended in a saline solution needed for the operation of the hardware molecule.

Details of the molecular computer were published April 28, 2004, in the online edition of Nature. They revealed that the input molecule is a double-stranded DNA molecule with a "sticky-end” single-stranded protrusion obtained by having one strand longer than the other. The software DNA molecules also have "sticky-ends,” each matching a different input combination. Through spontaneous DNA hybridization the input molecule and a matching software molecule temporarily bind to each other.

The hardware is an enzyme called FokI that attaches to DNA in a specifically coded location and cuts both strands at a fixed distance from that location, creating a sticky end. By employing additional chemical and mathematical tricks, the software molecules can be designed so that the hardware enzyme attaches to them and, once a software molecule hybridizes with an input molecule, the hardware enzyme cuts the input molecule in a programmed location, exposing a new sticky end that encodes the next state to be processed. The final sticky end, obtained at the end of the computation, encodes the computation result.

A unique property of the design of the molecular computer is that the DNA input molecule is also the source of the power that runs the computer. The energy is inherent to the chemical structure of DNA and is independent of the actual data it encodes, but is dependent on the length of the molecule.

Each molecular computer is rather slow. On average, it performs one operation per 20 seconds. On the other hand a 5 ml spoonful of these computers would be able to perform nearly 330 trillion operations per second, which is more than 100,000 times faster than the fastest personal computer, with an energy efficiency more than a million times that of a personal computer.

To demonstrate that the device actually works, the investigators successfully programmed the computer to identify and analyze mRNA of disease-related genes associated with models of small-cell lung cancer and prostate cancer, and to produce a single-stranded DNA molecule modeled after an anticancer drug.

Senior author Dr. Ehud Shapiro, a professor in the departments of computer sciences and applied mathematics at the Weizmann Institute said, "It is clear that the road to realizing our vision is a long one; it may take decades before such a system operating inside the human body becomes reality. Nevertheless, only two years ago we predicted that it would take another 10 years to reach the point we have reached today.”




Related Links:
Weizmann Institute of Science

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
All-in-One Molecular System
AIO M160
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Age-Based Genetic Testing May Miss Most Inherited Cancer Risk Variants

Inherited cancer risk can influence diagnosis, treatment planning, and family screening, yet current testing practices often depend on a patient’s age at diagnosis. Many patients undergo germline genetic... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.